Jeong, S. I., Kim, Y., Nah, J. J., Huh, W., Jang, I., Hwang, J. G., & Lee, S. (2023). Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium–glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults. British journal of clinical pharmacology, 89(6), 1780-1788. https://doi.org/10.1111/bcp.15632
Chicago Style (17th ed.) CitationJeong, Sae Im, Yun Kim, Jae Jin Nah, Wan Huh, In‐Jin Jang, Jun Gi Hwang, and SeungHwan Lee. "Pharmacokinetic and Pharmacodynamic Interaction of DWP16001, a Sodium–glucose Cotransporter 2 Inhibitor, with Gemigliptin and Metformin in Healthy Adults." British Journal of Clinical Pharmacology 89, no. 6 (2023): 1780-1788. https://doi.org/10.1111/bcp.15632.
MLA (9th ed.) CitationJeong, Sae Im, et al. "Pharmacokinetic and Pharmacodynamic Interaction of DWP16001, a Sodium–glucose Cotransporter 2 Inhibitor, with Gemigliptin and Metformin in Healthy Adults." British Journal of Clinical Pharmacology, vol. 89, no. 6, 2023, pp. 1780-1788, https://doi.org/10.1111/bcp.15632.